JFrog Ltd.
JFrog Ltd. (FROG) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for JFrog Ltd. (FROG), covering cash flow, earnings, and balance sheets.
JFrog Ltd. (FROG) Income Statement & Financial Overview
Review JFrog Ltd. FROG income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $122.41M | $116.08M | $109.06M | $103.04M |
| Cost of Revenue | $30.18M | $28.51M | $27.29M | $22.24M |
| Gross Profit | $92.23M | $87.57M | $81.77M | $80.81M |
| Gross Profit Ratio | $0.75 | $0.75 | $0.75 | $0.78 |
| R&D Expenses | $43.34M | $44.92M | $43.00M | $36.53M |
| SG&A Expenses | $71.86M | $68.06M | $68.69M | $63.16M |
| Operating Expenses | $115.20M | $112.98M | $111.69M | $98.58M |
| Total Costs & Expenses | $145.38M | $143.06M | $138.98M | $120.82M |
| Interest Income | $0.00 | $5.59M | $5.71M | $6.90M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $6.86M | $0.00 | $3.83M |
| EBITDA | -$22.97M | -$18.56M | -$29.92M | -$13.96M |
| EBITDA Ratio | -$0.19 | -$0.16 | -$0.27 | -$0.14 |
| Operating Income | -$22.97M | -$25.41M | -$29.92M | -$17.78M |
| Operating Income Ratio | -$0.19 | -$0.22 | -$0.27 | -$0.17 |
| Other Income/Expenses (Net) | $5.96M | $5.59M | $5.71M | $6.90M |
| Income Before Tax | -$17.005M | -$19.83M | -$24.21M | -$12.23M |
| Income Before Tax Ratio | -$0.14 | -$0.17 | -$0.22 | -$0.12 |
| Income Tax Expense | $1.50M | $3.37M | -$1.27M | $2.07M |
| Net Income | -$18.50M | -$23.20M | -$22.95M | -$14.30M |
| Net Income Ratio | -$0.15 | -$0.20 | -$0.21 | -$0.14 |
| EPS | -$0.16 | -$0.21 | -$0.21 | -$0.13 |
| Diluted EPS | -$0.16 | -$0.21 | -$0.21 | -$0.13 |
| Weighted Avg Shares Outstanding | $113.45M | $111.98M | $108.92M | $108.94M |
| Weighted Avg Shares Outstanding (Diluted) | $113.45M | $111.98M | $108.92M | $108.94M |
Over the past four quarters, JFrog Ltd. demonstrated steady revenue growth, increasing from $103.04M in Q2 2024 to $122.41M in Q1 2025. Operating income reached -$22.97M in Q1 2025, maintaining a consistent -19% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$22.97M, reflecting operational efficiency. Net income rose to -$18.50M, with EPS at -$0.16. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan